{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T22:27:53Z","timestamp":1758925673321,"version":"3.40.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,9,17]],"date-time":"2014-09-17T00:00:00Z","timestamp":1410912000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s00228-014-1724-8","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T01:18:32Z","timestamp":1410830312000},"page":"1333-1338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effect of two-linked mutations of the FMO3 gene on itopride metabolism in Chinese healthy volunteers"],"prefix":"10.1007","volume":"70","author":[{"given":"Li-Ping","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Rong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Gang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,17]]},"reference":[{"issue":"48","key":"1724_CR1","doi-asserted-by":"crossref","first-page":"7371","DOI":"10.3748\/wjg.v18.i48.7371","volume":"18","author":"X Huang","year":"2012","unstructured":"Huang X, Lv B, Zhang S, Fan Y-H, Meng L-N (2012) Itopride therapy for functional dyspepsia: a meta-analysis. World J Gastroenterol 18(48):7371\u20137377","journal-title":"World J Gastroenterol"},{"issue":"3","key":"1724_CR2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1254\/jjp.56.261","volume":"56","author":"YN Miyashita","year":"1991","unstructured":"Miyashita YN, Mizutani F, Morikawa K, Kato H, Ito Y (1991) Stimulatory effect of N-[4-[2-(dimethylamino)-ethoxy] benzyl]-3,4- dimethoxybenzamide hydrochloride (HSR-803) on normal and delayed gastrointestinal propulsion. Jpn J Pharmacol 56(3):261\u20139","journal-title":"Jpn J Pharmacol"},{"issue":"4","key":"1724_CR3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1254\/jjp.62.395","volume":"62","author":"Y Iwanaga","year":"1993","unstructured":"Iwanaga Y, Suzuki N, Kato K, Kimura T, Morikawa K, Kato H et al (1993) Stimulatory effects of HSR-803 on ileal motor activity. Jpn J Pharmacol 62(4):395\u2013401","journal-title":"Jpn J Pharmacol"},{"issue":"8","key":"1724_CR4","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJMoa052639","volume":"354","author":"G Holtmann","year":"2006","unstructured":"Holtmann G, Talley NJ, Liebregts T, Adam B, Parow C (2006) A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 354(8):832\u201340","journal-title":"N Engl J Med"},{"issue":"1","key":"1724_CR5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/j.1552-4604.1993.tb03904.x","volume":"33","author":"M Nakashima","year":"1993","unstructured":"Nakashima M, Uematsu T, Kanamaru M, Mizuno A, Matsubayashi K, Okazaki O et al (1993) Phase I study of DQ-2556, a new parenteral 3-quaternary ammonium cephalosporin antibiotic. J Clin Pharmacol 33(1):57\u201362","journal-title":"J Clin Pharmacol"},{"issue":"10","key":"1724_CR6","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0026-895X(24)12055-X","volume":"28","author":"T Mushiroda","year":"2000","unstructured":"Mushiroda T, Douya R, Takahara E, Nagata O (2000) The involvement of flavin-containing monooxygenase but not CYP3A4 in metabolism of itopride hydrochloride, a gastroprokinetic agent: comparison with cisapride and mosapride citrate. Drug Metab Dispos 28(10):1231\u20137","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"1724_CR7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1254\/jjp.84.213","volume":"84","author":"CS Park","year":"2000","unstructured":"Park CS, Roh HK, Lee WK, Cha YN (2000) Oxidation of ranitidine by isozymes of flavin-containing monooxygenase and cytochrome P450. Jpn J Pharmacol 84(2):213\u201320","journal-title":"Jpn J Pharmacol"},{"issue":"6","key":"1724_CR8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1365-2125.2000.00296.x","volume":"50","author":"E Stormer","year":"2000","unstructured":"Stormer E, Roots I, Brockmoller J (2000) Benzydamine N-oxidation as an index reaction reflecting FMO activity in human liver microsomes and impact of FMO3 polymorphisms on enzyme activity. Br J Clin Pharmacol 50(6):553\u201361","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"1724_CR9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1053\/cp.1999.v66.a102203","volume":"66","author":"C Sachse","year":"1999","unstructured":"Sachse C, Ruschen S, Dettling M, Schley J, Bauer S, Muller-Oerlinghausen B et al (1999) Flavin monooxygenase 3 (FMO3) polymorphism in a white population: allele frequencies, mutation linkage, and functional effects on clozapine and caffeine metabolism. Clin Pharmacol Ther 66(4):431\u20138","journal-title":"Clin Pharmacol Ther"},{"issue":"24","key":"1724_CR10","doi-asserted-by":"crossref","first-page":"8357","DOI":"10.1158\/1078-0432.CCR-04-1073","volume":"10","author":"IM Hisamuddin","year":"2004","unstructured":"Hisamuddin IM, Wehbi MA, Chao A, Wyre HW, Hylind LM, Giardiello FM et al (2004) Genetic polymorphisms of human flavin monooxygenase 3 in sulindac-mediated primary chemoprevention of familial adenomatous polyposis. Clin Cancer Res 10(24):8357\u201362","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1724_CR11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1124\/mol.105.012062","volume":"68","author":"SB Koukouritaki","year":"2005","unstructured":"Koukouritaki SB, Poch MT, Cabacungan ET, McCarver DG, Hines RN (2005) Discovery of novel flavin-containing monooxygenase 3 (FMO3) single nucleotide polymorphisms and functional analysis of upstream haplotype variants. Mol Pharmacol 68(2):383\u201392","journal-title":"Mol Pharmacol"},{"issue":"1","key":"1724_CR12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00008571-200002000-00009","volume":"10","author":"JH Kang","year":"2000","unstructured":"Kang JH, Chung WG, Lee KH, Park CS, Kang JS, Shin IC et al (2000) Phenotypes of flavin-containing monooxygenase activity determined by ranitidine N-oxidation are positively correlated with genotypes of linked FM03 gene mutations in a Korean population. Pharmacogenetics 10(1):67\u201378","journal-title":"Pharmacogenetics"},{"issue":"9181","key":"1724_CR13","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0140-6736(99)80019-1","volume":"354","author":"J Zschocke","year":"1999","unstructured":"Zschocke J, Kohlmueller D, Quak E, Meissner T, Hoffmann GF, Mayatepek E (1999) Mild trimethylaminuria caused by common variants in FMO3 gene. Lancet 354(9181):834\u20135","journal-title":"Lancet"},{"issue":"1","key":"1724_CR14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.aca.2006.09.061","volume":"583","author":"HW Lee","year":"2007","unstructured":"Lee HW, Seo JH, Choi SK, Lee KT (2007) Determination of itopride in human plasma by liquid chromatography coupled to tandem mass spectrometric detection: application to a bioequivalence study. Anal Chim Acta 583(1):118\u201323","journal-title":"Anal Chim Acta"},{"issue":"2","key":"1724_CR15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0090-9556(24)15124-0","volume":"28","author":"JR Cashman","year":"2000","unstructured":"Cashman JR, Akerman BR, Forrest SM, Treacy EP (2000) Population-specific polymorphisms of the human FMO3 gene: significance for detoxication. Drug Metab Dispos 28(2):169\u201373","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"1724_CR16","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1124\/dmd.30.10.1043","volume":"30","author":"JR Cashman","year":"2002","unstructured":"Cashman JR, Zhang J (2002) Interindividual differences of human flavin-containing monooxygenase 3: genetic polymorphisms and functional variation. Drug Metab Dispos 30(10):1043\u201352","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"1724_CR17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.pharmthera.2005.01.001","volume":"106","author":"KK Sharon","year":"2005","unstructured":"Sharon KK, David EW (2005) Mammalian flavin-containing monooxygenases: structure\/function, genetic polymorphisms and role in drug metabolism. Pharmacol Ther 106(3):357\u201387","journal-title":"Pharmacol Ther"},{"issue":"1","key":"1724_CR18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00008571-200201000-00011","volume":"12","author":"CS Park","year":"2002","unstructured":"Park CS, Kang JH, Chung WG, Yi HG, Pie JE, Park DK et al (2002) Ethnic differences in allelic frequency of two flavin-containing monooxygenase 3 (FMO3) polymorphisms: linkage and effects on in vivo and in vitro FMO activities. Pharmacogenetics 12(1):77\u201380","journal-title":"Pharmacogenetics"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-014-1724-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-014-1724-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-014-1724-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T16:54:09Z","timestamp":1746377649000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-014-1724-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,17]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["1724"],"URL":"https:\/\/doi.org\/10.1007\/s00228-014-1724-8","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2014,9,17]]}}}